TE_9
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluJr |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | ENSG00000293331 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 0.63 |
| Counts of samples | TCGA_tumor:142; TCGA_normal:10; GTEx:243 |
| TSS | chr1(-):612770 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_9.1 | ENSG00000293331 | Annoated | Non-coding | Non-coding | chr1(-):586338,586358,586821,586955,594629,594756,601398,601577,607955,608056,612741,612771 |
| teRNA_9.2 | ENSG00000293331 | Annoated | Non-coding | Non-coding | chr1(-):594736,594756,601398,601577,607955,608056,612741,612771 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
